Published in J Clin Pharmacol on March 01, 2005
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study. Neuro Oncol (2008) 0.84
Gadolinium- and 5-aminolevulinic acid-induced protoporphyrin IX levels in human gliomas: an ex vivo quantitative study to correlate protoporphyrin IX levels and blood-brain barrier breakdown. J Neuropathol Exp Neurol (2012) 0.83
Population pharmacokinetics and bioavailability of motexafin gadolinium (Xcytrin) in CD1 mice following intravenous and intraperitoneal injection. Invest New Drugs (2006) 0.75
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med (2013) 16.24
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol (2013) 5.21
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Default mode network activity and connectivity in psychopathology. Annu Rev Clin Psychol (2012) 3.49
Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One (2008) 3.32
Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial. J Clin Oncol (2012) 3.28
The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol (2011) 3.01
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol (2003) 2.69
Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol (2004) 2.55
Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Hum Brain Mapp (2009) 2.28
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Fine-tuning of auditory cortex during speech production. Psychophysiology (2005) 1.94
Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies. J Magn Reson Imaging (2012) 1.86
Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. Lancet HIV (2015) 1.77
Impaired visual cortical plasticity in schizophrenia. Biol Psychiatry (2012) 1.67
Relationship of imprecise corollary discharge in schizophrenia to auditory hallucinations. Arch Gen Psychiatry (2007) 1.66
Does food supplementation really enhance productivity of breeding birds? Oecologia (2010) 1.64
Brain regions associated with psychological pain: implications for a neural network and its relationship to physical pain. Brain Imaging Behav (2013) 1.56
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet (2013) 1.55
Anatomy of an error: ERP and fMRI. Biol Psychol (2003) 1.52
Response-monitoring dysfunction in schizophrenia: an event-related brain potential study. J Abnorm Psychol (2002) 1.50
Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol (2002) 1.47
Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans. Hum Genet (2013) 1.43
Widespread cortical dysfunction in schizophrenia: the FBIRN imaging consortium. Schizophr Bull (2008) 1.39
Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy. J Clin Oncol (2010) 1.37
Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol (2012) 1.34
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial. Int J Radiat Oncol Biol Phys (2008) 1.33
Comparison of the DNA methylation profiles of human peripheral blood cells and transformed B-lymphocytes. Hum Genet (2010) 1.31
The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J Virol (2006) 1.28
Reduced auditory evoked potential component N100 in schizophrenia--a critical review. Psychiatry Res (2008) 1.24
Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. Schizophr Bull (2010) 1.21
N400 and automatic semantic processing abnormalities in patients with schizophrenia. Arch Gen Psychiatry (2002) 1.21
Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry (2011) 1.20
A multi-site resting state fMRI study on the amplitude of low frequency fluctuations in schizophrenia. Front Neurosci (2013) 1.15
Transmediastinal gunshot wounds in a mature trauma centre: changing perspectives. Injury (2013) 1.14
Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer. J Clin Oncol (2010) 1.12
Are impairments of action monitoring and executive control true dissociative dysfunctions in patients with schizophrenia? Am J Psychiatry (2003) 1.09
Surgical training and clinical trial involvement--the trainees' view. BMJ (2015) 1.08
Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet (2015) 1.03
NCoR1 mediates papillomavirus E8;E2C transcriptional repression. J Virol (2010) 1.02
Brd4 regulation of papillomavirus protein E2 stability. J Virol (2009) 1.02
Genetics of coronary artery calcification among African Americans, a meta-analysis. BMC Med Genet (2013) 0.99
Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder. Front Hum Neurosci (2010) 0.98
Immunoglobulin aggregation leading to Russell body formation is prevented by the antibody light chain. Blood (2009) 0.98
Perceptual measurement in schizophrenia: promising electrophysiology and neuroimaging paradigms from CNTRICS. Schizophr Bull (2011) 0.98
The corollary discharge in humans is related to synchronous neural oscillations. J Cogn Neurosci (2010) 0.98
Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women. J Clin Oncol (2010) 0.98
Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia. Schizophr Bull (2005) 0.97
Stereotactic radiation treatment for recurrent nonbenign meningiomas. J Neurosurg (2007) 0.97
The role of organizational culture and leadership in water safety plan implementation for improved risk management. Sci Total Environ (2010) 0.97
Neurocognitive and functional assessment of patients with brain metastases: a pilot study. Am J Clin Oncol (2003) 0.96
CNTRICS final biomarker selection: Control of attention. Schizophr Bull (2011) 0.96
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei. Clin Cancer Res (2006) 0.95
Auditory cortex responsiveness during talking and listening: early illness schizophrenia and patients at clinical high-risk for psychosis. Schizophr Bull (2011) 0.94
Response-monitoring dysfunction in aging and Alzheimer's disease: an event-related potential study. Neurobiol Aging (2003) 0.93
Heritability of urinary traits that contribute to nephrolithiasis. Clin J Am Soc Nephrol (2014) 0.93
The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals. J Gen Virol (2011) 0.92
Relationships between pre-stimulus γ power and subsequent P300 and reaction time breakdown in schizophrenia. Int J Psychophysiol (2010) 0.91
Selective attention in schizophrenia: sparing and loss of executive control. Am J Psychiatry (2004) 0.91
Neurobiology of schizophrenia: search for the elusive correlation with symptoms. Front Hum Neurosci (2012) 0.91
Genome-wide association study of gene by smoking interactions in coronary artery calcification. PLoS One (2013) 0.90
Corollary discharge dysfunction in schizophrenia: evidence for an elemental deficit. Clin EEG Neurosci (2008) 0.90
Automatic semantic priming abnormalities in schizophrenia. Int J Psychophysiol (2009) 0.89
Gene-specific DNA methylation association with serum levels of C-reactive protein in African Americans. PLoS One (2013) 0.89
Online GESS: prediction of miRNA-like off-target effects in large-scale RNAi screen data by seed region analysis. BMC Bioinformatics (2014) 0.89
Epigenetic Signatures of Cigarette Smoking. Circ Cardiovasc Genet (2016) 0.88
Error monitoring dysfunction across the illness course of schizophrenia. J Abnorm Psychol (2011) 0.88
DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. Hum Mol Genet (2013) 0.88
Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2007) 0.88
MRI measurement of the uptake and retention of motexafin gadolinium in glioblastoma multiforme and uninvolved normal human brain. J Neurooncol (2006) 0.87
Deficient Suppression of Default Mode Regions during Working Memory in Individuals with Early Psychosis and at Clinical High-Risk for Psychosis. Front Psychiatry (2013) 0.87
Heavy chain-only antibodies are spontaneously produced in light chain-deficient mice. J Exp Med (2007) 0.85
Error detection failures in schizophrenia: ERPs and FMRI. Int J Psychophysiol (2009) 0.85
Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer. J Thorac Oncol (2014) 0.85
An ICA with reference approach in identification of genetic variation and associated brain networks. Front Hum Neurosci (2012) 0.85
The neurophysiology of auditory hallucinations - a historical and contemporary review. Front Psychiatry (2011) 0.85
Alternative methods for measuring obesity in African American women. Yale J Biol Med (2013) 0.83
Frontally mediated inhibitory processing and white matter microstructure: age and alcoholism effects. Psychopharmacology (Berl) (2010) 0.83
Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer. N Engl J Med (2014) 0.83
KGraph: a system for visualizing and evaluating complex genetic associations. Bioinformatics (2006) 0.83
Initial clinical results of stereotactic radiotherapy for the treatment of craniopharyngiomas. Technol Cancer Res Treat (2002) 0.83
Prediction of neurocognitive outcome in adult brain tumor patients. J Neurooncol (2004) 0.83
Block in development at the pre-B-II to immature B cell stage in mice without Ig kappa and Ig lambda light chain. J Immunol (2003) 0.83
Expression of a dromedary heavy chain-only antibody and B cell development in the mouse. J Immunol (2005) 0.82
Exacerbation of myasthenia gravis after tourniquet release. J Clin Anesth (2007) 0.81
Corrigendum: Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat Genet (2016) 0.81
Early auditory gamma-band responses in patients at clinical high risk for schizophrenia. Suppl Clin Neurophysiol (2013) 0.80
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer. Clin Colorectal Cancer (2013) 0.80
Divergent approaches converge on frontal lobe dysfunction in schizophrenia. Am J Psychiatry (2008) 0.80
Reductase-mediated metabolism of motexafin gadolinium (Xcytrin) in rat and human liver subcellular fractions and purified enzyme preparations. J Pharm Sci (2005) 0.79
Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2. Virology (2009) 0.79
Validation and use of three complementary analytical methods (LC-FLS, LC-MS/MS and ICP-MS) to evaluate the pharmacokinetics, biodistribution and stability of motexafin gadolinium in plasma and tissues. Anal Bioanal Chem (2006) 0.79
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 Study. Pancreas (2016) 0.78
Suicidal crises because of diminishing tolerance to psychological pain. Brain Imaging Behav (2013) 0.78